Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Fibrates in the treatment of dyslipidemias--time for a reassessment.

Goldfine AB, Kaul S, Hiatt WR.

N Engl J Med. 2011 Aug 11;365(6):481-4. doi: 10.1056/NEJMp1106688. No abstract available.

PMID:
21830963
2.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

3.

[Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].

Pérez A.

Endocrinol Nutr. 2010 Dec;57(10):457-9. doi: 10.1016/j.endonu.2010.05.010. Epub 2010 Aug 4. Spanish. No abstract available.

PMID:
20688585
4.

Retinopathy progression in type 2 diabetes.

Baum SJ.

N Engl J Med. 2010 Nov 25;363(22):2172; author reply 2173-4. doi: 10.1056/NEJMc1009236#SA3. No abstract available.

PMID:
21105808
5.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
6.
7.

Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.

Jones PH.

Am J Cardiol. 2007 Feb 19;99(4A):133B-140B. Epub 2006 Dec 28. Review.

PMID:
17307065
8.

Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.

Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT.

Am J Cardiol. 2010 Dec 1;106(11):1594-601. doi: 10.1016/j.amjcard.2010.07.041. Epub 2010 Oct 14.

PMID:
21094360
9.
10.

[Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].

Båvenholm P, Attvall S, Nilsson PM.

Lakartidningen. 2006 Aug 30-Sep 5;103(35):2462-6. Review. Swedish. No abstract available.

PMID:
17002161
11.

Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.

[No authors listed]

Cardiovasc J Afr. 2008 May-Jun;19(3):171-2. No abstract available.

12.

Interpreting clinical trials of diabetic dyslipidaemia: new insights.

Wierzbicki AS.

Diabetes Obes Metab. 2009 Mar;11(3):261-70. Epub 2007 Jul 21.

PMID:
17645560
13.

[On behalf and the extent of evidence].

Ruiz J.

Rev Med Suisse. 2010 Jun 9;6(252):1171-2. French. No abstract available.

PMID:
20614750
14.

Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.

Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP.

Am J Cardiol. 2008 Jun 1;101(11):1679-80. doi: 10.1016/j.amjcard.2008.02.087. No abstract available. Erratum in: Am J Cardiol. 2008 Jul 15;102(2):248. Koragiannis, Asterios [corrected to Karagiannis, Asterios]; Mikhalidis, Dimitri P [corrected to Mikhailidis, Dimitri P].

PMID:
18489951
15.

Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.

[No authors listed]

Cardiovasc J Afr. 2009 Jan-Feb;20(1):73-4. No abstract available.

16.

Management of dyslipidemias in patients with diabetes and chronic kidney disease.

Molitch ME.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. Epub 2006 Jul 26. Review.

17.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators..

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
18.

Lipid therapy in the elderly--emphasis on clinical event reduction and safety.

Lavie CJ, Milani RV.

Am J Geriatr Cardiol. 2006 Jul-Aug;15(4):245-7. No abstract available.

PMID:
16849891
19.
20.

Is it time to stop treating dyslipidaemia with fibrates?

Benatar JR, Stewart RA.

N Z Med J. 2007 Sep 7;120(1261):U2706. Review.

PMID:
17853928

Supplemental Content

Support Center